PRODIGE 53-UCGI 30 (SULTAN): A randomized phase II study comparing treatment intensification with hepatic arterial infusion chemotherapy plus systemic chemotherapy to systemic chemotherapy alone in patients with liver-only colorectal metastases considered still non resectable after at least two months of systemic induction chemotherapy.

Valérie Boige,Jean-Pierre Pignon,Mathilde Wagner,Eric Dupont-Bierre,Samuel Le Sourd,Franck Audemar,Ayhan Ulusakarya,Veronique Guerin-Meyer,Veronica Pezzella,Maximiliano Gelli,Diane Goéré,Julien Taieb

PRODIGE 53-UCGI 30 (SULTAN): A randomized phase II study comparing treatment intensification with hepatic arterial infusion chemotherapy plus systemic chemotherapy to systemic chemotherapy alone in patients with liver-only colorectal metastases considered still non resectable after at least two months of systemic induction chemotherapy.

2019

Valérie Boige
Jean-Pierre Pignon
Mathilde Wagner
Eric Dupont-Bierre
Samuel Le Sourd
Franck Audemar
Ayhan Ulusakarya
Veronique Guerin-Meyer
Veronica Pezzella
Maximiliano Gelli
Diane Goéré
Julien Taieb

TPS3619Background: In the first-line setting, current combination chemotherapy (CT) achieve high objective response rates (ORR) ranging from 40% to 80% and leads to complete resection rate (CRR) of...

Keywords:

Hepatic arterial infusion chemotherapy
Phases of clinical research
Gastroenterology
Pathology
Induction chemotherapy
Internal medicine
Medicine
Chemotherapy
combination chemotherapy
systemic chemotherapy
in patient
complete resection
treatment intensification

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations